Overview

A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia

Status:
Terminated
Trial end date:
2015-08-28
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of intravenous micafungin for the treatment of patients with proven or probable fungal infections caused by Candida sp. (Fungemia, respiratory mycosis, gastrointestinal mycosis) in adult patients in China.
Phase:
Phase 4
Details
Lead Sponsor:
Astellas Pharma China, Inc.
Treatments:
Echinocandins
Micafungin